| Original language | English |
|---|---|
| Article number | e74133 |
| Journal | PLoS ONE |
| Volume | 8 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published (VoR) - 11 Nov 2013 |
Funding
This study was funded by a commercial sponsor, Glaxosmithkline (GSK). CMD, FS, PL, GB, KM, AS, SRM, SMH, ETB and PJN are employees of GSK and own shares in the company. RH is a paid consultant for GSK. KM has received consultancy fees from Lundbeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.